Candidate Molecules as Tumor Suppressor for Human Uterine Mesenchymal Tumor

Journal Title: IOSR Journal of Pharmacy (IOSRPHR) - Year 2013, Vol 3, Issue 8

Abstract

 Uterine leiomyosarcoma (Ut-LMS) develops more often in myometrium of the uterine body than in the uterine cervix. The development of gynecologic tumors is often correlated with female hormone secretion; however, the development of Ut-LMS is not substantially correlated with hormonal conditions, and the risk factor(s) are not yet known. Importantly, a diagnostic-biomarker, which distinguishes malignant tumor Ut-LMS from benign tumor leiomyoma (LMA), is yet to be established. Accordingly, it is necessary to examine risk factor(s) associated with Ut-LMS, to establish a diagnosis and a clinical treatment method. The mice with a homozygous deficiency for proteasome -ring subunit, low-molecular mass polypeptide (LMP)2/1i spontaneously develop Ut-LMS, with a disease prevalence of ~37% by 12 months of age. In the recent study, we found LMP2/1i expression to be absent in human Ut-LMS, but clearly present in other human uterine mesenchymal tumors including uterine LMA. Further analyses with clinical materials and the gene-modified mice have not clarified the biological significance of the TP53 and retinoblastoma (Rb) pathway in malignant myometrium transformation, thus implicating LMP2/1i as an anti-tumorigenic candidate. This role of LMP2/1i as a tumor suppressor may lead to new therapeutic targets in human Ut-LMS. (191 words)

Authors and Affiliations

Takuma Hayashi , Akiko Horiuchi

Keywords

Related Articles

 A case of allergy and food sensitivity: the nasunin, natural color of eggplant

 llergies and food sensitivities can both be considered as "adverse reactions individualistic" to food. Are pathological and individual forms because they affect a few individuals in way rather serious; immediate&n...

 Development and Validation of a Simple UV Spectrophotometric Method for the Determination of Cefotaxime Sodium in Bulk And Pharmaceutical Formulation

 The present study was undertaken to develop and validate a simple, accurate, precise, reproducible and cost effective UV-Visible spectrophotometric method for the estimation of cefotaxime sodium in bulk and pharm...

 “Hemodynamic and recovery profile with Dexmedetomidine and  Fentanyl in intracranial supratentorial surgeries: A comparative study”

 Dexmedetomidine (DEX) has shown analgesic effects without significant respiratory depression. As Dexmedetomidine (DEX) provides good perioperative hemodynamic stability with decreased intraoperative opioid re...

 Comparative study of medicinal plant (azadirachta indica) with diclofenac on anti-inflammatory activity

 The inflammation is a biologically action on living tissue heomeostasis. Acute inflammation causes by bacterial infection, tissue necrosis and sign of inflammation are heat (calor), pain (dolor), redness(rubor), s...

Download PDF file
  • EP ID EP120557
  • DOI -
  • Views 117
  • Downloads 0

How To Cite

Takuma Hayashi, Akiko Horiuchi (2013).  Candidate Molecules as Tumor Suppressor for Human Uterine Mesenchymal Tumor. IOSR Journal of Pharmacy (IOSRPHR), 3(8), 31-37. https://www.europub.co.uk/articles/-A-120557